← Back to Vaccine Database

mRNA-1283

RNA based vaccine · VDDBV0504

Target & Classification

SARS-CoV-2SARS-CoV-2
RNA based vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT04813796 Phase 1COVID-19
NCT05137236 Phase 2COVID-19